Unfortunately, despite the necessity of detecting and implementing into clinical practice new biomarkers for HCC [77], the evidence regarding the role of NLRP3 as a biomarker in HCC is limited. This evidence concerns the gene NLRP3 and hepatocellular carcinoma.